| NCT06972602 |
High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed (ClinicalTrials.gov ↗) Retinoblastoma, Retinoblastoma, Recurrent |
Phase EARLY_PHASE1 |
Recruiting |
Eye & ENT Hospital of Fudan University |
China |
| NCT04799002 |
Topotecan and Melphalan for Retinoblastoma (ClinicalTrials.gov ↗) Retinoblastoma, Chemotherapy Effect |
Phase 3 |
Recruiting |
Sun Yat-sen University |
China |
| NCT06203210 |
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer (ClinicalTrials.gov ↗) Small Cell Lung Cancer |
Phase 3 |
Recruiting |
Daiichi Sankyo |
USA, China |
| NCT06394492 |
SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer (ClinicalTrials.gov ↗) Ovarian Cancer |
Phase 3 |
Recruiting |
Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
China |
| NCT06498479 |
ARTEMIS-008๏ผHS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer (ClinicalTrials.gov ↗) Small Cell Lung Cancer |
Phase 3 |
Recruiting |
Hansoh BioMedical R&D Company |
China |
| NCT06801834 |
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer (ClinicalTrials.gov ↗) Extensive Stage Small Cell Lung Cancer (ES-SCLC) |
Phase 3 |
Recruiting |
Gilead Sciences |
UK, USA, China |
| NCT06855069 |
HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer (ClinicalTrials.gov ↗) Ovarian Cancer |
Phase 3 |
Recruiting |
Hansoh BioMedical R&D Company |
China |
| NCT06954246 |
A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer (ClinicalTrials.gov ↗) Small Cell Lung Cancer Extensive Stage |
Phase 3 |
Recruiting |
Qilu Pharmaceutical Co., Ltd. |
China |
| NCT06994195 |
A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01) (ClinicalTrials.gov ↗) Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer |
Phase 3 |
Recruiting |
Sichuan Baili Pharmaceutical Co., Ltd. |
China |
| NCT07099898 |
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) Neoplasms, Lung |
Phase 3 |
Recruiting |
GlaxoSmithKline |
Ireland, UK, USA |
| NCT07213804 |
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms |
Phase 3 |
Recruiting |
Eli Lilly and Company |
Ireland, UK, USA, China |
| NCT07218809 |
AZD5335 vs. Mirvetuximab Soravtansine in FRฮฑ-high and AZD5335 vs. Chemotherapy in FRฮฑ-low Platinum-resistant Ovarian Cancer Epithelial Ovarian Cancer |
Phase 3 |
Recruiting |
AstraZeneca |
Ireland, UK, USA, India, China |
| NCT07365241 |
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer (ClinicalTrials.gov ↗) Small Cell Lung Cancer |
Phase 3 |
Recruiting |
AbbVie |
USA |
| NCT07604766 |
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in China (ClinicalTrials.gov ↗) Platinum-resistant Ovarian Cancer |
Phase 3 |
Recruiting |
Genmab |
China |
| NCT06161025 |
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (ClinicalTrials.gov ↗) Solid Cancer |
Phase 2/3 |
Recruiting |
Daiichi Sankyo |
UK, USA, China |
| NCT05652686 |
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) (ClinicalTrials.gov ↗) Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) |
Phase 1/2 |
Recruiting |
Phanes Therapeutics |
USA |
| NCT06930755 |
Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer Ovarian Cancer |
Phase 1 |
Recruiting |
Nerviano Medical Sciences |
USA |
| NCT07545460 |
A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With HER2-Expressing Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer (ClinicalTrials.gov ↗) Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer |
Phase 3 |
Not yet open |
Sichuan Baili Pharmaceutical Co., Ltd. |
China |
| NCT07797153 |
JSKN033 Versus Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer (ClinicalTrials.gov ↗) Recurrent or Metastatic Cervical Cancer |
Phase 3 |
Not yet open |
Jiangsu Alphamab Biopharmaceuticals Co., Ltd |
China |
| NCT05303727 |
Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma (ClinicalTrials.gov ↗) Neuroblastoma |
Phase 2 |
Not yet open |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
China |
| NCT05740566 |
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer (ClinicalTrials.gov ↗) Small Cell Lung Cancer (SCLC) |
Phase 3 |
Active, closed |
Amgen |
Ireland, UK, USA, China |
| NCT06459180 |
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20) Cervical Cancer |
Phase 3 |
Active, closed |
Merck Sharp & Dohme LLC |
Ireland, UK, USA, China |
| NCT06616532 |
PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer (ClinicalTrials.gov ↗) SCLC |
Phase 3 |
Active, closed |
Biotheus Inc. |
China |
| NCT06619236 |
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer (ClinicalTrials.gov ↗) Platinum-resistant Ovarian Cancer |
Phase 3 |
Active, closed |
Genmab |
USA, China |
| NCT03709680 |
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors (ClinicalTrials.gov ↗) Ewing Sarcoma, Solid Tumors, Rhabdoid Tumor |
Phase 2 |
Active, closed |
Pfizer |
UK, USA, India |
| NCT06449209 |
Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy (ClinicalTrials.gov ↗) Extensive-stage Small-cell Lung Cancer, Small-cell Lung Cancer |
Phase 2 |
Active, closed |
BioNTech SE |
UK, USA |
| NCT04106219 |
A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma Neuroblastoma |
Phase 1 |
Active, closed |
Eli Lilly and Company |
UK, USA |
| NCT05990738 |
DAREONโข-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy (ClinicalTrials.gov ↗) Small Cell Lung Carcinoma (SCLC) |
Phase 1 |
Active, closed |
Boehringer Ingelheim |
UK, USA |